National Mar 5, 2021
Japan's Takeda seeks government approval for Moderna COVID-19 vaccine
While awaiting regulatory approval, Takeda plans to start distributing the Moderna vaccine in the first half of this year.
Japan's Takeda seeks government approval for Moderna COVID-19 vaccine
While awaiting regulatory approval, Takeda plans to start distributing the Moderna vaccine in the first half of this year.
Biden expects enough vaccine supplies for all American adults by end of May
U.S. President Joe Biden announced Tuesday that there would be enough doses of the coronavirus vaccine available for the entire adult population in the United States by the end of May, although he said it would take longer to actually inoculate everyone, and he ...
Moderna and Takeda to seek COVID-19 vaccine approval in Japan
The request, which could come as early as Friday, will be the third such application for regulatory approval.
J&J's vaccine is expected to be used widely around the globe because it can be shipped and stored at normal refrigerator temperatures, making distribution easier.
Survey shows many of Japan's seniors are undecided about COVID-19 vaccines
A survey conducted on people who require home nursing care earlier this month showed 43% were unsure about receiving shots while 15% were against it entirely.
Japan on high alert for COVID-19 vaccination scams
Vaccine-linked scams emerged in January, according to an official, when the approach of the vaccine program quickly captured national attention.
Pfizer-BioNTech shot could help end pandemic, Israel study shows
It was the largest study yet to quantify the impact of the vaccine outside the rigorous confines of a randomized, blinded clinical trial aimed at measuring effectiveness for regulators.
Takeda starts clinical trial of Novavax COVID-19 vaccine in Japan
The drugmaker said it expects to gain results from a study on 200 Japanese participants age 20 or older in the second half of this year.
One shot or two? Japan weighs question as vaccine rollout stalls amid shortages
Health minister Norihisa Tamura says Japan will stick to the standard two-dose schedule, but some in the LDP are calling for a change of course.
AstraZeneca to miss EU vaccine supply target by half in second quarter
The expected shortfall follows a big reduction in supplies in the first quarter and could hit the EU's ability to meet its target of vaccinating 70% of adults by summer.
Pfizer-BioNTech shot stops COVID-19 spread, Israeli study shows
The study provides the first real-world indication that the immunization will curb transmission of the coronavirus, but experts cautioned that more data is needed.
Fujifilm to restart trial of Avigan to treat COVID-19, report says
Domestic approval of the drug was delayed after a health ministry panel said in December that trial data was inconclusive.